Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
job ratings (see below graph) for Amgen
latest headlines for company on cafepharma
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Motley Fool
Wed, 02/9/11 - 01:14 pm
Tags:
Amgen
,
AMG785
,
denosumab
,
osteoporosis
FDA Says Drug Firms Didn't Finish Follow-Ups
WSJ Online
Wed, 02/9/11 - 11:16 am
Tags:
FDA
,
cancer
,
Roche
,
GSK
,
Eli Lilly
,
AstraZeneca
,
Amgen
The Magic Formula for These Biotech Stocks
Motley Fool
Wed, 01/26/11 - 08:55 pm
Tags:
biotech
,
Amgen
,
Biogen Idec
,
Gilead Sciences
,
Celgene
Amgen Makes Bet on Viral Skin Cancer Killer
TheStreet.com
Wed, 01/26/11 - 12:22 pm
Tags:
skin cancer
,
Amgen
,
BioVex
,
M&A
Amgen’s Purchase of Cancer Drugmaker Biovex May Mean More Deals
Bloomberg
Tue, 01/25/11 - 09:30 am
Tags:
Amgen
,
BioVex
,
cancer
,
M&A
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Bloomberg
Mon, 01/24/11 - 08:22 pm
Tags:
BioVex
,
Amgen
,
M&A
,
Oncovex
Amgen earns $1 billion in fourth quarter
Marketwatch
Mon, 01/24/11 - 06:28 pm
Tags:
earnings
,
Amgen
Amgen Raises Prices to Offset Anemia-Drug Slowdown
Bloomberg
Mon, 01/24/11 - 11:39 am
Tags:
anemia
,
Amgen
,
Aranesp
Amgen will report 4th-quarter financial results after the market closes Monday
Yahoo/AP
Mon, 01/24/11 - 11:16 am
Tags:
Amgen
,
earnings
Why Big Pharma Is the New Big Biotech
Seeking Alpha
Fri, 01/21/11 - 07:57 am
Tags:
Big Pharma
,
Amgen
,
Celgene
,
Gilead Sciences
,
Roche
Biotech Firms Fight Generics
WSJ Online
Thu, 01/13/11 - 01:14 pm
Tags:
generics
,
biotech
,
Amgen
,
Pfizer
,
Enbrel
,
Epogen
,
anemia
,
Biogen Idec
,
MS
,
Avonex
,
multiple sclerosis
,
arthritis
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:24 pm
Tags:
Watson Pharmaceuticals
,
Theratechnologies
,
Shire
,
Savient
,
Sanofi
,
Roche
,
Orphan Europe
,
Novo Nordisk
,
Novartis
,
Merz
,
JNJ
,
HRA Pharma
,
Genzyme
,
Forest Labs
,
FDA
,
Eisai
,
Dainippon Sumitomo
,
Chemiche Fabrik Kresussler
,
Boehringer Ingelheim
,
Bayer
,
Auxilium
,
Amgen
,
Allergan
,
Acorda Therapeutics
Amgen Exec: “Clearly Superior” Prostate Cancer Drug Will Be Huge
Forbes
Mon, 01/10/11 - 08:04 pm
Tags:
prostate cancer
,
Amgen
,
Prolia
,
Xgeva
Amgen Wins Ruling Blocking Teva’s Generic Sensipar
Bloomberg
Sat, 01/8/11 - 11:52 am
Tags:
Amgen
,
Teva Pharmaceuticals
,
Sensipar
Amgen licenses Xencor's early-stage autoimmune drug
Fierce Biotech
Fri, 01/7/11 - 10:04 am
Tags:
Amgen
,
Xencor
,
autoimmune disease
Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Fri, 01/7/11 - 07:21 am
Tags:
Oncothyreon
,
Xoma
,
Amarin
,
Opexa
,
Human Genome
,
Seattle Genetics
,
Vertex Pharmaceuticals
,
Merck
,
Dendreon
,
Biogen Idec
,
Amgen
,
Pharmasset
Drug Stocks Ended Mostly Lower (King Pharmaceuticals, AMGN, ARNA, XOMA)
Wall Street Bay
Sun, 01/2/11 - 12:24 pm
Tags:
King
,
Amgen
,
Arena Pharmaceuticals
,
Xoma
2011 Big-Cap Biotech Preview
TheStreet.com
Wed, 12/22/10 - 09:21 am
Tags:
biotech
,
Celgene
,
Amgen
,
Biogen Idec
,
Gilead Sciences
,
Genzyme
,
Sanofi
Drug Companies Stocks Underperfomed: AMGN, NVO, JNJ
Trader's Huddle
Sat, 12/18/10 - 12:44 pm
Tags:
Amgen
,
Novo Nordisk
,
JNJ
Amgen Drug Meets Primary Endpoint
Yahoo/Zacks
Sat, 12/18/10 - 12:35 pm
Tags:
Xgeva
,
Amgen
,
prostate cancer
,
Zometa
Pages
« first
‹ previous
…
90
91
92
93
94
95
96
97
98
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.